
141 episodes

BioTalk with Rich Bendis BioHealth Innovation, Inc. (BHI)
-
- Business
-
-
4.7 • 11 Ratings
-
BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.
Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries.
Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.
-
Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO
Join us for an insightful episode of BioTalk as host Rich Bendis welcomes back Rachel King, the visionary CEO of the Biotechnology Innovation Organization (BIO), bringing with her a remarkable journey spanning roles as an entrepreneur, board member, and advocate for the biotech industry.
In this engaging installment, Rachel offers a glimpse into her evolution from consulting to industry, including her role as co-founder and former CEO of GlycoMimetics, Inc. (GMI). Discover the essence of BIO, its mission, and the global perspective it brings to the biotech landscape. Delve into Rachel's advocacy role and the critical issues facing the industry today, including pricing, congressional relations, and investment challenges. Gain insights into the state of the biotech industry and Rachel's projections for both the near and long term.
Listen as we unravel the dynamic journey of Rachel King, a trailblazing leader in biotechnology, and gain a comprehensive perspective on the industry's present and future. Available now on all major podcasting platforms. -
Nurturing Tomorrow's STEM Leaders: A Conversation with Dr. Judy Staveley, Biotechnologist and STEM Advocate
Explore the world of scientific mentorship and education with Dr. Judy Staveley, an accomplished Chief Biotechnologist and STEM advocate. In this episode of BioTalk, Dr. Staveley discusses her journey in supporting young scientists and her roles in organizations like the National Association of Academies of Science (NAAS) and the American Junior Academy of Science (AJAS).
Discover the upcoming NAAS/AJAS STEM EDUCATION CONFERENCE/FUNDRAISER on September 16th and its impact on inspiring the next generation of innovators. Learn about AJAS's life science support programs that encourage young talents to pursue careers in STEM.
Dr. Staveley shares insights into STEM education in the BioHealth Capital Region and her personal goals for nurturing young scientists. Join us to uncover the pivotal role of mentorship in shaping the future of STEM. Listen now on major podcasting platforms. -
BioTalk Discusses Breaking Frontiers in Immunotherapy: A Conversation with Bill Enright, CEO and Board Director at Vaccitech
What does it take to pioneer groundbreaking T-cell immunotherapies and vaccines for infectious diseases and cancer? Join us for this episode of BioTalk, where we sit down with Bill Enright, a seasoned biotech executive with a remarkable track record spanning over three decades. Bill brings a wealth of experience in building and financing both privately held and publicly traded companies, making his mark in various roles within the life science/biotech industry.
Bill offers a compelling update in this installment since his previous appearance on BioTalk. Learn about the intriguing journey that led Vaccitech, a clinical-stage T cell immunotherapy and vaccine company, to select Montgomery County, MD, within the thriving BioHealth Capital Region, for its new site. Delve into the intricacies of their pioneering platform, which harnesses the power of immunotherapy to elicit robust T cell responses and antibodies against infectious agents and tumors.
Get an insider's perspective as Bill provides clinical updates on their groundbreaking work, discussing major milestones in critical areas like HBV, HPV, PCA, and VTB, among others. Explore Vaccitech's path forward as Bill sheds light on their next significant milestones and strategic plans to expand their presence within the United States.
Don't miss this exclusive conversation with Bill Enright as he shares insights into the dynamic world of immunotherapy and Vaccitech's mission to transform the disease treatment and prevention landscape. -
How the BioHealth Capital Region Became a Top 3 BioPharma Cluster: Insights from Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News
How does a BioPharma Cluster ascend the ranks to secure a Top 3 position? What are the key factors propelling the BioHealth Capital Region to achieve its ambitious goal of ranking 3rd by 2023? Join us in this episode of BioTalk, where our host Rich Bendis speaks with Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News.
In this installment, Alex unveils the intricacies behind his latest Top 10 U.S. Biopharma Clusters, highlighting the impressive rise of the BioHealth Capital Region to its 3rd position. Learn about the origins of these rankings, the trends that have been identified for 2023, and the dynamic shifts within the BioPharma landscape on a regional scale.
Discover the journey of the Maryland/Virginia/Washington, DC, BioHealth Capital Region, which has realized its vision of securing a prominent seat among the top echelons of biopharma clusters. With an astounding portfolio of 52,899 patents, this achievement reflects the prolific presence of esteemed institutions such as Johns Hopkins, NIH, and the National Library of Medicine. Tune in to learn about the region's significant accomplishments, including its impressive 6,201 NIH funding awards amounting to $4.245 billion, and a sprawling 31.69 million square feet of cutting-edge lab space.
Join us as we unravel the insights that have propelled the BioHealth Capital Region to the forefront of BioPharma innovation and growth. -
Navigating Growth and Collaboration in Life Sciences: A Conversation with Brad L. Stewart, SVP of Business Development, MCEDC
How does a region evolve to become a leading driver in the BioHealth Capital Region? What are the secrets behind the successful collaboration between various organizations like MCEDC (Montgomery County Economic Development Corporation), MTC (Maryland Tech Council), and the Maryland Department of Commerce? How does a serial biotech entrepreneur leverage his experience to grow a diverse cross-section of businesses, including life sciences, technology, cybersecurity, defense, and hospitality?
In this episode of BioTalk, host Rich Bendis chats with Brad L. Stewart, SVP of Economic Development for Montgomery County Economic Development Corporation (MCEDC). Brad's multifaceted career spans from being a Chief Executive Officer to leading expert teams in strategy and innovation, plus economic development specialists in Montgomery County.
Together, they delve into the MCEDC Life Science support programs, the remarkable evolution of the region over the last 20 years, Brad's new role as Chair of MTC, and the shared values and collaboration in the region. They also celebrate Brad's achievements and discuss the current state of the Life science industry, especially in MOCO and BHCR.
Join this engaging conversation to uncover the strategies and insights that have shaped Montgomery County's economy and the life sciences field. Learn from Brad's leadership and his ability to thrive on complex strategic opportunities. Tune in to this episode of BioTalk to explore the innovative and collaborative spirit that's driving growth and success in the industry. -
Building Better Medicine, and Transformative Partnerships: Insights from Joy Polefrone, Ph.D. on BioTalk
Ever wondered how public-private partnerships can make a significant difference in the field of life sciences? Curious about the goals, expected impacts, and timeline of the Alliance for Building Better Medicine (ABBM)? Interested in exploring the transformative potential of the Virginia BioHealth ecosystem and its role in advancing the life sciences industry?
In this episode of BioTalk, join host Rich Bendis as he interviews Joy Polefrone, Ph.D., Executive Director of the Alliance for Building Better Medicine (ABBM). Joy brings two decades of diverse business leadership and organizational strategy experience. They discuss career shifts in academia, industry, and non-profits, the creation and mission of ABBM, consortium building for the Build Back Better Challenge, funding and match partners, goals and expected impacts, the Virginia BioHealth ecosystem, and the role of public-private partnerships.
Discover how Joy's multifaceted perspective helps resolve complex problems and build leaders, teams, and organizations aligned with their values. Gain valuable insights into the transformative potential of public-private partnerships in the life sciences field. Don't miss this opportunity to hear about future goals and directions for ABBM and learn from Joy's seasoned leadership in the industry. Tune in to this engaging episode of BioTalk.
Customer Reviews
Insights into the mid Atlantic BioHealth sector
A great insiders view of biotech players in the DC region.
Great podcast about BioHealth Capital Region
Excellent resource for anyone looking to learn about the leaders, challenges and missions of the members of the BioHealth Capital Region; the biotech, academic and government research community, as well as the pharmaceutical and manufacturing industry of the D.C. metropolitan area.